Stonepine Capital Management’s AYTU BioPharma AYTU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.16M	Sell	792,289 -21,415	-3%	-$54.8K	0.87%	21
2025 Q4	$2.12M	Sell	813,704 -78,151	-9%	-$175K	1.54%	21
2025 Q3	$1.68M	Buy	891,855 +79,179	+10%	+$183K	1.36%	19
2025 Q2	$1.77M	Buy	812,676 +348,955	+75%	+$542K	1.74%	16
2025 Q1	$795K	Buy	463,721 +56,172	+14%	+$81.7K	0.77%	27
2024 Q4	$693K	Sell	407,549 -93,409	-19%	-$171K	0.56%	35
2024 Q3	$1.18M	Buy	500,958 +28,489	+6%	+$73.8K	0.74%	25
2024 Q2	$1.38M	Hold	472,469	–	–	1.26%	15
2024 Q1	$1.44M	Hold	472,469	–	–	1.14%	14
2023 Q4	$1.34M	Buy	472,469 +100	+0%	+$275	0.58%	14
2023 Q3	$1.28M	Hold	472,369	–	–	0.42%	23
2023 Q2	$756K	Buy	+472,369	New	+$927K	0.27%	21
2021 Q2	–	Sell	-18,146	Closed	-$2.76M	–	28
2021 Q1	$2.76M	Sell	18,146 -51,793	-74%	-$8.22M	1.49%	18
2020 Q4	$8.37M	Buy	+69,939	New	+$12.7M	6.4%	4